Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion type Assertion NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_head.
- NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion description "[Loss of heterozygosity studies in melanoma and pancreatic carcinoma from gene carriers strongly support the view that CDKN2 is a general tumour suppressor gene predisposing not only to melanoma but also to other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_provenance.
- NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion evidence source_evidence_literature NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_provenance.
- NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion SIO_000772 7640518 NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_provenance.
- NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion wasDerivedFrom befree-2016 NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_provenance.
- NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_assertion wasGeneratedBy ECO_0000203 NP1316248.RA4SvkJpxibZePayWZH2rxiGD4Mr06Rs47_d7p1YHZ6Cw130_provenance.